Thick Needle Biopsy: What Should You Know?

After the area is cleaned and numbed, a clinician guides a hollow needle into the target, sometimes using ultrasound, CT, or MRI images. The device removes one or more cores, which are sent to pathology. The laboratory looks at the tissue architecture and may use immunohistochemistry to identify proteins that help classify the cells.

The report may describe whether the tissue is benign, cancerous, inflammatory, or insufficient for a firm conclusion. Further genomic tumour profiling can sometimes examine features relevant to treatment selection. A core biopsy does not remove every abnormal area and is not itself a treatment.

Tell the biopsy team about blood thinners, bleeding disorders, allergies, pregnancy, and any medicines or supplements. Follow instructions about eating, drinking, and arranging transport if sedation is planned. Afterward, keep the dressing clean, avoid strenuous activity for the advised period, and use only the pain relief recommended for you.

Ask when the pathology report is expected and who will discuss it. If the sample is limited or the findings do not explain the scan, your team may suggest another sample or a different test.

Contact the biopsy service for bleeding that does not stop with firm pressure, worsening swelling, spreading redness, pus, fever, or pain that is getting worse. Seek emergency help for severe shortness of breath, fainting, or heavy uncontrolled bleeding.

Why is a core sample preferred for this target? Will imaging guide the needle? How should I manage blood-thinning medicines? What will the pathology and possible marker tests tell us?